Accessibility Menu
 
NanoViricides logo

NanoViricides

(NYSEMKT) NNVC

Current Price$0.98
Market Cap$22.24M
Since IPO (2005)-93%
5 Year-80%
1 Year-22%
1 Month-1%

NanoViricides Financials at a Glance

Market Cap

$22.24M

Revenue (TTM)

$0.00

Net Income (TTM)

$8.32M

EPS (TTM)

$-0.48

P/E Ratio

-2.14

Dividend

$0.00

Beta (Volatility)

0.82 (Low)

Price

$0.98

Volume

113,418

Open

$1.01

Previous Close

$1.03

Daily Range

$0.98 - $1.02

52-Week Range

$0.85 - $2.23

NNVC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NanoViricides

Industry

Biotechnology

Employees

7

CEO

Anil R. Diwan, PhD

Headquarters

Shelton, CT 06484, US

NNVC Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-78%

Return on Capital

-0%

Return on Assets

-0%

Earnings Yield

-46.73%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$22.24M

Shares Outstanding

21.59M

Volume

113.42K

Short Interest

0.00%

Avg. Volume

276.91K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$9.59M

EBITDA

$8.72M

Operating Cash Flow

$8.48M

Capital Expenditure

$56.96K

Free Cash Flow

$8.54M

Cash & ST Invst.

$1.56M

Total Debt

$0.00

NanoViricides Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$133.08K

N/A

Gross Margin

0.00%

N/A

Market Cap

$22.24M

N/A

Market Cap/Employee

$3.18M

N/A

Employees

7

N/A

Net Income

$2.22M

-9.5%

EBITDA

$2.10M

-14.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$5.15T

+130129064.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-0.00%

N/A

Return on Invested Capital

-0.00%

N/A

Free Cash Flow

$3.73T

-170146860.4%

Operating Cash Flow

$3.64T

-166298479.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EVAXEvaxion Biotech A/S
$3.79-3.07%
JSPRJasper Therapeutics, Inc.
$1.19-3.25%
IGCIGC Pharma, Inc.
$0.27-4.89%
GBIOGeneration Bio Co.
$5.34+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$44.56+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.83+0.06%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$77.52-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.56-0.03%

Questions About NNVC

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.